Your browser doesn't support javascript.
loading
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Bonomi, P D; Gandara, D; Hirsch, F R; Kerr, K M; Obasaju, C; Paz-Ares, L; Bellomo, C; Bradley, J D; Bunn, P A; Culligan, M; Jett, J R; Kim, E S; Langer, C J; Natale, R B; Novello, S; Pérol, M; Ramalingam, S S; Reck, M; Reynolds, C H; Smit, E F; Socinski, M A; Spigel, D R; Vansteenkiste, J F; Wakelee, H; Thatcher, N.
Afiliación
  • Bonomi PD; Department of Internal Medicine, Rush University Medical Center, Chicago, USA. Electronic address: pbonomi@rush.edu.
  • Gandara D; Department of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, USA.
  • Hirsch FR; University of Colorado Cancer Center, Aurora, USA.
  • Kerr KM; Department of Pathology, Aberdeen University Medical School and Aberdeen Royal Infirmary Foresterhill, Aberdeen, UK.
  • Obasaju C; Eli Lilly and Company, Indianapolis, USA.
  • Paz-Ares L; Hospital Universitario Doce de Octubre, Universidad Complutense, CiberOnc & CNIO, Madrid, Spain.
  • Bellomo C; Intermountain Cancer Center, Cedar City Hospital, Cedar City, USA.
  • Bradley JD; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, USA.
  • Bunn PA; University of Colorado Cancer Center, Aurora, USA.
  • Culligan M; Division of Thoracic Surgery, University of Maryland School of Medicine, Baltimore, USA.
  • Jett JR; Emeritus, National Jewish Health, Denver, USA.
  • Kim ES; Levine Cancer Institute, Atrium Health, Charlotte, USA.
  • Langer CJ; Department of Thoracic Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, USA.
  • Natale RB; Cedars-Sinai Comprehensive Cancer Center, West Hollywood, USA.
  • Novello S; Department of Oncology, University of Turin, Turin, Italy.
  • Pérol M; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, USA.
  • Reck M; Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Reynolds CH; Florida Cancer Specialists, Ocala, USA.
  • Smit EF; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, the Netherlands.
  • Socinski MA; Florida Hospital Cancer Institute, Orlando, USA.
  • Spigel DR; Sarah Cannon Research Institute, Nashville, USA.
  • Vansteenkiste JF; Respiratory Oncology Unit, Department of Respiratory Medicine, University Hospital KU Leuven, Leuven, Belgium.
  • Wakelee H; Stanford University School of Medicine, Stanford, USA.
  • Thatcher N; The Christie NHS Foundation Trust, Manchester, UK.
Ann Oncol ; 29(8): 1701-1709, 2018 08 01.
Article en En | MEDLINE | ID: mdl-29905778
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article